In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Tandem Diabetes Care Inc’s stock clocked out at $20.62, up 1.63% from its previous closing price of $20.29. In other words, the price has increased by $1.63 from its previous closing price. On the day, 0.68 million shares were traded. TNDM stock price reached its highest trading level at $21.15 during the session, while it also had its lowest trading level at $20.5.
Ratios:
To gain a deeper understanding of TNDM’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 274.69. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 2.93. In the meantime, Its Debt-to-Equity ratio is 1.80 whereas as Long-Term Debt/Eq ratio is at 1.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on March 05, 2025, Downgraded its rating to Equal-Weight and sets its target price to $22 from $45 previously.
On March 04, 2025, Citigroup Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $35 to $24.
Wells Fargo Downgraded its Overweight to Equal Weight on March 03, 2025, whereas the target price for the stock was revised from $38 to $22.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Kyrillos Jean-Claude bought 10,538 shares for $18.12 per share. The transaction valued at 190,966 led to the insider holds 10,538 shares of the business.
BLICKENSTAFF KIM D sold 30,000 shares of TNDM for $941,400 on Nov 21 ’24. The Director now owns 165,190 shares after completing the transaction at $31.38 per share. On Nov 20 ’24, another insider, BLICKENSTAFF KIM D, who serves as the Director of the company, sold 10,000 shares for $30.00 each. As a result, the insider received 300,000 and left with 195,190 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNDM now has a Market Capitalization of 1370679552 and an Enterprise Value of 1410714880. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.46 while its Price-to-Book (P/B) ratio in mrq is 5.19. Its current Enterprise Value per Revenue stands at 1.5 whereas that against EBITDA is -17.095.
Stock Price History:
The Beta on a monthly basis for TNDM is 1.51, which has changed by -0.38794893 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, TNDM has reached a high of $53.69, while it has fallen to a 52-week low of $17.64. The 50-Day Moving Average of the stock is -30.01%, while the 200-Day Moving Average is calculated to be -43.46%.
Shares Statistics:
It appears that TNDM traded 1.49M shares on average per day over the past three months and 1648690 shares per day over the past ten days. A total of 66.26M shares are outstanding, with a floating share count of 65.92M. Insiders hold about 0.83% of the company’s shares, while institutions hold 111.57% stake in the company. Shares short for TNDM as of 1740700800 were 7135022 with a Short Ratio of 4.77, compared to 1738281600 on 6930585. Therefore, it implies a Short% of Shares Outstanding of 7135022 and a Short% of Float of 16.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
